O-Desmethyl-cis-tramadol

Advanced Clinical Toxicology & Mu-Opioid Receptor Profiling

When forensic toxicologists need to source O-Desmethyl-cis-tramadol for the calibration of high-resolution mass spectrometry, acquiring a definitively characterized opioid metabolite is critical. Created as an experimental chemical for testing, this compound acts as a potent agonist of the μ-opioid receptor. Because clandestine networks continuously alter chemical scaffolds, facilities that acquire O-Desmethyl-cis-tramadol rely on this >99.9% pure reference standard to map metabolic pathways and differentiate synthetic artifacts in complex biological matrices.

Core Spectrometric & Pharmacological Parameters

• Chemical Classification: Synthetic Opioid Analgesic / Tramadol Metabolite
• IUPAC Nomenclature: rel-3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]-phenol, monohydrochloride
• Primary Diagnostic Ion (LC-MS/MS ESI+): Precursor-to-product transitions targeting the cyclohexyl ring cleavage
• Certified Purity: ≥99.0% (Verified via quantitative HPLC-UV & NMR)
• Intended Application: Urine drug testing, pain prescription monitoring, and forensic analysis.

Clandestine Diversion & Global Street-Level Masking

In international customs databases, synthetic opioids are frequently intercepted after being repackaged. This compound is the active component in the designer drug “Krypton,” historically marketed as a legal high. These substances are routinely seized and mislabeled globally: as Legal Opioids or Tramadol analogs (USA), Krypton or Research Opiates (Europe), Designer painkillers (Australia), and Synthetic analgesics (Asia). This deliberate mislabeling is exactly why public health labs acquire O-Desmethyl-cis-tramadol reference standards to prove misrepresentation and track international adulteration networks.

OSINT Forums & Synthetic Opioid Monitoring

To anticipate new analog emergence, forensic chemists monitor underground communities. Facilities analyzing this compound cross-reference analytical data with anecdotal reports found on niche platforms. For ongoing opioid tracking, analysts frequently reference:

• Erowid Vaults: Cross-referencing historical pharmacological data to understand legacy opioid stability and dosage thresholds.
• Bluelight.org: Reviewing the Emerging Drugs board for real-world adverse event reports and cutting agent profiles.
• Reddit Communities: Analyzing r/ResearchChemicals and r/chemistry for global precursor trends and analytical warnings.

By leveraging these networks, researchers who source O-Desmethyl-cis-tramadol can optimize their chromatographic methods while adhering to strict laboratory safety limits.

Analytical Differentiation & Metabolic Mapping

O-Desmethyltramadol is an active primary blood metabolite of the synthetic analgesic tramadol, possessing a stronger effect than its parent compound. ChemNexis Pharma synthesizes O-Desmethyl-cis-tramadol in compliance with modern laboratory standards to ensure absolute baseline accuracy. This certified solution standard is suitable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications, including clinical toxicology.

Statutory Compliance & Analytical Handling

Adverse properties of this specific isomer have not been fully studied in clinical literature, making definitive analytical baselines essential. Human beings are not eligible for consuming this drug. Researchers are strictly using this material as a research chemical in forensic laboratories. Facilities that source O-Desmethyl-cis-tramadol must maintain strict chain-of-custody logs and store the compound in a cool and dry place, ensuring stability for up to 2 years under the right storage conditions.

STATUTORY COMPLIANCE NOTICE: This reference material is provided strictly for in-vitro analytical research, spectrometric calibration, and educational chemistry. It is explicitly NOT intended for human or animal consumption. End-users must comply with all local precursor monitoring regulations.

Frequently Asked Questions (FAQ)

Q: How does the cis-isomer configuration affect mass spectrometry fragmentation?
A: The cis-configuration yields distinct secondary fragment ions during tandem mass spectrometry. Analysts utilizing O-Desmethyl-cis-tramadol can easily distinguish these specific signatures from the trans-isomer or standard tramadol.

Q: Is derivatization required for GC-MS profiling?
A: Yes. Derivatization using BSTFA or MSTFA is highly recommended to protect the hydroxyl and phenol groups, preventing thermal degradation in the GC inlet and ensuring sharp, reproducible chromatographic peaks.

Q: Will this compound trigger standard workplace drug screens?
A: Standard immunoassays may show cross-reactivity with tramadol, but definitive identification of this specific metabolite requires chromatographic confirmation, which is why toxicologists source O-Desmethyl-cis-tramadol.

Complementary Forensic Reference Materials:

Expand your analytical library by pairing this opioid standard with our other verified synthetic CRMs:

• Synthetic Opioid & Analgesic Catalog
• Novel Psychoactive Substances (NPS) Catalog